Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ardelyx Inc (ARDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 195,160
  • Shares Outstanding, K 47,600
  • Annual Sales, $ 42,000 K
  • Annual Income, $ -64,340 K
  • 36-Month Beta 0.79
  • Price/Sales 4.59
  • Price/Cash Flow N/A
  • Price/Book 1.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.37
  • Low Estimate -0.39
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.80 +7.89%
on 08/08/18
4.70 -12.77%
on 07/18/18
-0.45 (-9.89%)
since 07/13/18
3-Month
3.58 +14.53%
on 07/02/18
5.90 -30.51%
on 05/18/18
-1.35 (-24.77%)
since 05/14/18
52-Week
3.58 +14.53%
on 07/02/18
8.65 -52.60%
on 10/12/17
-1.00 (-19.61%)
since 08/14/17

Most Recent Stories

More News
Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights

Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the second quarter ended June 30, 2018.

ARDX : 4.10 (+1.23%)
Ardelyx, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Ardelyx, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time.

ARDX : 4.10 (+1.23%)
What's in Store for Penumbra (PEN) This Earnings Season?

Penumbra (PEN) deepens focus on driving innovation, ramping up production and expanding geographies.

EYE : 43.63 (-0.27%)
NTRA : 25.15 (-1.33%)
PEN : 122.65 (+0.90%)
ARDX : 4.10 (+1.23%)
Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings?

Henry Schein (HSIC) is strongly placed to gain from the ongoing trend of digitalization in the global dental market.

EYE : 43.63 (-0.27%)
NTRA : 25.15 (-1.33%)
HSIC : 78.25 (+0.55%)
ARDX : 4.10 (+1.23%)
Free Technical Research Reports on Biotech Stocks -- Versartis, VIVUS, Xenetic Biosciences, and Ardelyx

If you want a free Stock Review on VSAR, VVUS, XBIO, and ARDX sign up now at https://stocktraderreport.com/registration/. On Friday, July 27, 2018, the NASDAQ Composite closed the trading session at 7,737.42,...

VSAR : 1.75 (+6.06%)
VVUS : 0.65 (-2.99%)
XBIO : 3.47 (-14.95%)
ARDX : 4.10 (+1.23%)
Top Ranked Momentum Stocks to Buy for July 26th

Top Ranked Momentum Stocks to Buy for July 26th

BLFS : 20.50 (-0.19%)
APOG : 49.76 (+1.18%)
ARDX : 4.10 (+1.23%)
Free Technical Reports on Array BioPharma and Three Additional Biotech Equities

Stock Research Monitor: ARDX, BOLD, and AUPH

ARRY : 14.27 (-2.59%)
BOLD : 33.38 (-5.09%)
ARDX : 4.10 (+1.23%)
Consolidated Research: 2018 Summary Expectations for CorVel, Consol Energy, Ardelyx, Aevi Genomic Medicine, Proofpoint, and Brink's -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CorVel Corp. (NASDAQ:CRVL),...

GNMX : 0.96 (-2.04%)
CRVL : 58.05 (+1.66%)
ARDX : 4.10 (+1.23%)
CEIX : 43.43 (+0.84%)
PFPT : 116.97 (+0.38%)
BCO : 78.45 (+0.84%)
Bruce Walton Named President and COO of Aurora Diagnostics

Aurora Diagnostics announced today that Bruce Walton, the company's Executive Vice President and Chief Operating Officer (COO) since January 2015, has been promoted to President and COO.

ARDX : 4.10 (+1.23%)
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights

Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018.

ARDX : 4.10 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ARDX with:

Business Summary

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase...

See More

Key Turning Points

2nd Resistance Point 4.13
1st Resistance Point 4.12
Last Price 4.10
1st Support Level 4.07
2nd Support Level 4.03

See More

52-Week High 8.65
Fibonacci 61.8% 6.71
Fibonacci 50% 6.11
Fibonacci 38.2% 5.52
Last Price 4.10
52-Week Low 3.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar